Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

VASCULAR SOLUTIONS LLC

Subsidiary ofTELEFLEX MEDICAL GROUPUEI: CMZHMVNAALR1CAGE: 1SG48

VASCULAR SOLUTIONS LLC is a federal contractor, registered under UEI CMZHMVNAALR1 and CAGE code 1SG48. It has been awarded $15,635,539 in federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), Unknown NAICS, and Surgical and Medical Instrument Manufacturing. Top awarding agencies include Department Of Defense, Department Of Veterans Affairs, and Other agencies (1 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

CMZHMVNAALR1

CAGE Code

1SG48

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

339112Surgical and Medical Instrument Manufacturing
339113Surgical Appliance and Supplies Manufacturing
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

VASCULAR SOLUTIONS LLC specializes in advanced biomedical research and development focused on battlefield medical readiness, particularly in the stabilization and delivery of blood-derived therapeutics for austere environments. Their technical expertise centers on lyophilization processes, freeze-dr...

VASCULAR SOLUTIONS LLC specializes in advanced biomedical research and development focused on battlefield medical readiness, particularly in the stabilization and delivery of blood-derived therapeutics for austere environments. Their technical expertise centers on lyophilization processes, freeze-dried plasma formulation, and commercial viability assessment of cryoprecipitate products designed for far-forward military operations. The company demonstrates deep proficiency in translational biomedical engineering, applying physical and life science principles to solve critical logistics challenges in military medicine, including shelf-stable plasma preservation, thermal stability optimization, and process scalability under operational constraints. Their work bridges laboratory innovation with field-deployable solutions, emphasizing rapid deployment, ambient temperature storage, and compatibility with combat medevac protocols. The contractor’s primary agency engagement is with the Department of Defense, where they deliver R&D solutions under broad agency announcements targeting combat casualty care. Their work supports special operations forces by developing next-generation hemostatic and plasma-based interventions that enhance survivability in remote, high-threat environments. This sustained partnership indicates a trusted role in DOD’s medical innovation pipeline, particularly within SOCOM’s research ecosystem. VASCULAR SOLUTIONS LLC operates under NAICS 541715, focusing exclusively on physical, engineering, and life sciences research outside nanotechnology and biotechnology. This positions them as a niche provider in applied biomedical engineering for defense applications, specializing in non-recombinant, plasma-derived therapeutics and process development for military medical logistics. Their market niche is defined by practical, field-validated solutions rather than broad pharmaceutical development. As a small business structured as a 2L entity based in Maple Grove, MN, VASCULAR SOLUTIONS LLC maintains a focused, mission-driven presence in the federal defense R&D market. While currently without formal government certifications, their specialized technical execution and direct engagement with DoD research initiatives underscore a credible capability profile in high-stakes medical innovation.

Key Performance Metrics

Awards Count

1,069

All time

Active

0

Currently performing

Completed

1,069

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Defense$12.8M82%Department Of Veterans Affairs$2.1M13.3%
$742.4K4.8%
Other agencies (1 agencies, <0.5% each)$6.3K0%
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with VASCULAR SOLUTIONS LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for VASCULAR SOLUTIONS LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in VASCULAR SOLUTIONS LLC's top NAICS codes and agencies

NAICS: 541715
New
Federal
Mobile Integrated Launch Capability
Solicitation # 26-MDA-12366
The Missile Defense Agency (MDA) is soliciting innovative and cost-efficient alternatives to current C-17 air drop target launches through the Mobile Integrated Launch Capability (MILC) program. The objective is to develop mobile launch platforms capable of deploying short to long-range target missile systems, including ballistic, air-breathing, and maneuvering targets, from various global locations via ground, sea, or air. This effort is structured in two phases: Phase I focuses on detailed design, engagement analysis, and prototype costing with an objective period of three months; Phase II involves prototyping, ground testing, and the delivery of one launch platform for a demonstration launch, with an objective period of twelve months. The solicitation follows a two-step competitive process based on the evaluation of white papers, which are judged on technical merit, innovation, potential utility to agency programs, schedule adherence, and lifecycle cost. Offerors must be registered in the System for Award Management and maintain an active Secret Facility Clearance to handle classified information. Procurement may be executed through Revolutionary Federal Acquisition Regulation (RFO) based contracts or Other Transaction (OT) agreements, the latter of which prioritize commercial industry standards. Submissions must include a detailed program plan, a Rough Order of Magnitude cost estimate, and a full disclosure of any organizational conflicts of interest.
Missile Defense Agency (mda)

POSTED

2 days ago

DEADLINE

in almost 2 years
View Details
NAICS: 541715
New
Federal
MTEC Solicitation Summary: Fiscal Year 2026 Multi-Topic Request for Project Proposals
Solicitation # MTEC-26-04-MultiTopic
The Medical Technology Enterprise Consortium (MTEC), in collaboration with the Defense Health Agency, is soliciting project proposals under solicitation MTEC-26-04-MultiTopic for medical prototype technological and knowledge solutions. Authorized under 10 U.S.C. section 4022 and utilizing an Other Transaction Agreement, this effort seeks to modernize medical capabilities to maintain force readiness and soldier lethality in future multi-domain conflicts. The solicitation covers 16 distinct Focus Areas, including behavioral health, physical fitness, wound infection prevention, sepsis treatment, musculoskeletal injury interventions, non-addictive analgesics, blast and blunt impact sensors, and a multisite clinical biomarker platform for lung and kidney failure. Proposals are submitted via a two-stage Enhanced White Paper process, where selected Stage 1 submissions are invited to provide full cost proposals in Stage 2. To be eligible, projects must demonstrate clear military relevance, meet a minimum Knowledge/Technology Readiness Level of 3, and fit the specific definition of a prototype rather than being exploratory. Additionally, solutions must not have been submitted to MTEC within the last two years. While average initial awards range from 2.0 to 3.5 million dollars over a two to three year period, specific funding and performance periods vary by Focus Area. Teaming is encouraged, and successful projects may be eligible for non-competitive follow-on tasks.
Defense Health Agency

POSTED

2 days ago

DEADLINE

in 19 days
View Details
NAICS: 541715
New
Federal
Atomically Precise Molecules (APM)
Solicitation # DARPA-PS-26-141
The Defense Advanced Research Projects Agency (DARPA) Multi X Office is soliciting proposals for the Atomically Precise Molecules (APM) program under solicitation DARPA-PS-26-141. The program aims to develop innovative synthesis techniques for programmable precision polymers (PPPs) and nonlinear optical (NLO) materials to overcome performance gaps in optical communications and LiDAR. The primary objective is the creation of scalable, fit-for-purpose materials, culminating in a prototype demonstration of a revolutionary NLO material integrated into a government-provided electro-optic modulator. Research focusing solely on inorganic materials or incremental improvements to the state-of-the-art is specifically excluded. This 36-month effort is structured in two technical phases, with Phase I focusing on developing PPP synthesis capabilities over the first 12 months. Awards will be issued as Other Transaction (OT) for Prototype Agreements under 10 U.S.C. 4022. Key requirements include CMMC Level 2 self-assessment compliance and adherence to a program-specific Controlled Unclassified Information (CUI) guide. Non-US organizations, FFRDCs, UARCs, and government entities are ineligible to serve as prime performers, though FFRDCs and UARCs may participate as subawardees provided they meet specific certification and conflict of interest mitigation requirements. Proposals must be submitted via the Broad Agency Announcement Tool (BAAT) by December 18, 2026. Submissions must include a technical and management volume, a price proposal with a detailed spreadsheet, a Task Description Document, and a schedule of milestones and payments. Evaluation will be based on the technical approach, relevance to the DARPA mission, budget realism, and the capability to transition the technology to military or commercial sectors. Payments are milestone-based and processed through the Wide Area Workflow (WAWF) system.
Defense Advanced Research Projects Agcy

POSTED

2 days ago

DEADLINE

in 2 months
View Details